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Model building and reﬁnement of complexes between bio-
macromolecules and small molecules requires sensible starting
coordinates as well as the speciﬁcation of restraint sets for all
but the most common non-macromolecular entities. Here, it is
described why this is necessary, how it can be accomplished
and what pitfalls need to be avoided in order to produce
chemically plausible models of the low-molecular-weight
entities. A number of programs, servers, databases and other
resources that can be of assistance in the process are also
discussed.
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1. The null hypothesis
When the crystal structure of a complex between a macro-
molecule and a small molecule is determined, the null
hypothesis is usually: ‘My crystal contains the compound I
soaked in or cocrystallized with and it hasideal geometry’.The
assumption of ideal geometry is usually warranted, although
one has to keep in mind that deviations may occur owing to
steric strain, unexpected effects of pH or ionic strength etc.
However, the ﬁrst assumption should indeed be that the
geometry is ‘ideal’ and only very convincing density in high-
resolution maps should be allowed to tempt one to depart
from that assumption. In most cases, the major problem will be
to deﬁne the restraints that are necessary to impose the ideal
geometry, as well as to ﬁnd the appropriate (‘ideal’) target
values for those restraints. This issue is discussed in detail
below. However, before discussing restraints we should brieﬂy
examine the other assumption that is made in the null
hypothesis, namely that the crystal contains the expected
compound. There are a number of circumstances that can
invalidate this assumption. A trivial one is the fact that the
crystal is bound to contain much more than just the macro-
molecule and the small molecule of interest: any molecules
retained during puriﬁcation, components of the crystallization
soup, cryoprotectant etc. In many cases, therefore, interpreting
density features can be a major obstacle in and of itself. Some
of the automated methods described elsewhere in this issue
may be of assistance in such cases (Evrard et al., 2007;
Terwilliger et al., 2007). In addition, as the examples below
show, compounds (known and unknown) may undergo
chemical reactions, ‘known’ compounds may turn out to be
something completely different and sometimes a putative
ligand simply does not bind or binds with too low an occu-
pancy to give a clear feature in the electron density.
Depending on the nature of the small molecule and the
environment inside the protein, a ligand may be reduced or
oxidized (e.g. sulfur- or metal-containing compounds), it may
form dimers (e.g.  -mercaptoethanol may dimerize to form2-hydroxyethyldisulﬁde), it may turn out to be an unexpected
substrate or it may react with the protein or other components
present in the crystal. An interesting example of an unex-
pected reaction taking place in a crystal (albeit with an
unusual amino acid rather than a ligand) was encountered in
the structure determination of a methanogen methyltrans-
ferase, the ﬁrst known protein to contain a copy of the 22nd
naturally occurring amino acid, l-pyrrolysine (Hao et al.,
2002). Crystals were obtained with both sodium chloride and
ammonium sulfate. However, the unusual amino acid had
undergone a spontaneous addition reaction (of an amine
group; 60% occupancy) in the crystals grown with ammonium
sulfate (Hao et al., 2002).
A communication problem caused confusion during the
reﬁnement of a complex of cellular retinoic acid-binding
protein II with a synthetic retinoid that was supposed to be
TTNPB (Fig. 1; Kleywegt et al., 1994). However, persistent
features in subsequent difference maps suggested that the
ligand was something else. After consultation with the
synthetic chemists half a world away, it turned out that the
compound they had supplied was in fact a different synthetic
retinoid, ‘compound 19’ (Fig. 1; Kleywegt et al., 1994; Davis et
al., 2003).
Sometimes a ligand simply does not bind (or binds with too
low occupancy or with too much disorder) and this may
explain what happened in the structure determination of a
complex between botulinum neurotoxin type B protease and
an inhibitor (Hanson et al., 2000). Close inspection of the maps
after publication convinced the authors that these did ‘not
support the placement of the inhibitor as stated in the paper’
and the structure was retracted (Hanson et al., 2002; Fig. 2).
2. The need for restraints
Macromolecular X-ray crystallography is a notoriously poor
method for determining the structure of small molecules that
are bound to macromolecules and it has been pointed out by a
number ofpeople that the stereochemical quality of more than
a few small-molecule structures encountered in the worldwide
Protein Data Bank (wwPDB; Berman et al., 2003) is less than
overwhelming (van Aalten et al., 1996; Kleywegt & Jones,
1998; Kleywegt, 2000; Bostro ¨m, 2001; Nissink et al., 2002;
Davis et al., 2003; Kleywegt et al., 2003; Schu ¨ttelkopf & van
Aalten, 2004; Lu ¨tteke & von der Lieth, 2004). Part of the
explanation of this phenomenon lies in the general limitations
of macromolecular crystallography, namely limited resolution
(and information content) and weak data (leading to a low
signal-to-noise ratio). This means that in typical cases the
data-to-parameter ratio is of the order of 0.5–5, where one
would prefer to have values in excess of 10. The lack of data
can to some extent be compensated for by the use of prior
knowledge in the model reﬁnement process. The data-to-
parameter ratio can be improved by reducing the number of
model parameters (by applying constraints) or by increasing
the number of observations (in the form of restraints). A
constraint imposes an exact condition and thereby removes
one or more parameters from the model. Examples of
constraints include the use of strict noncrystallographic
symmetry (NCS), rigid-body reﬁnement, reﬁnement of overall
or grouped temperature factors and model parameterization
in torsion-angle space (in which bond lengths and angles can
be kept ﬁxed during reﬁnement). A restraint expresses
empirical knowledge (or expectations) regarding the chem-
istry or physics of a system in the form of a condition on one or
more parameters (often in the form of a target value for a
single parameter, with some indication of the allowed devia-
tions from that value). Examples include restraints on bond
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Figure 1
Chemical structure diagrams of (a) TTNPB and (b) ‘compound 19’.
Figure 2
Electron density for the inhibitor BABIM (shown with gold C atoms) in
its complex with botulinum neurotoxin type B protease (Hanson et al.,
2000, 2002). The map is a 2mFo   DFc synthesis, calculated with all
deposited data (2.5 A ˚ ), and taken from EDS (Kleywegt et al., 2004). Figs.
2 and 3 were created with O (Jones et al., 1991) and MolRay (Harris &
Jones, 2001).lengths (either by specifying a target length or by specifying
that all bonds of a certain type should have roughly the same
length), bond angles, certain ‘ﬁxed’ torsion angles, planar
groups, repulsion between non-bonded atoms and tempera-
ture-factor differences between related atoms.
Reﬁnement programs incorporate restraints into the target
function (i.e. the function that is minimized, which can be a
least-squares, maximum-likelihood or energy-based function)
by adding empirical restraint functions that take different
functional forms depending on the nature of the restraints. For
instance, bond-length restraints are conveniently implemented
by adding a quadratic penalty or cost function of the type
’bonds ¼
P
bonds !ðdmodel   didealÞ
2;
where ! is a weight, dmodel is a bond length in the model, dideal
is the target value for that bond and the sum extends over all
covalent bonds in the model. For restrained reﬁnement of a
model three things are needed: a set of deﬁnitions (atom types,
bonds, angles, planar groups etc.), a set of target (‘ideal’)
values for the restraints and appropriate weights for the
individual restraints and for the restraint functions (to deter-
mine the relative importance of the experimental data and the
restraints). In the following, this collection of items will be
called a restraint set, but it goes by many other names:
(stereochemical) dictionary, library, force ﬁeld or topology
and parameter deﬁnitions. The various types of (stereo-
chemical) restraints and their use in reﬁnement will not be
discussed here. Instead, the reader is referred to the paper by
Evans in this issue (Evans, 2007), to other review papers
(Hendrickson, 1985; Kleywegt et al., 2003; Tronrud, 2004) and
to standard textbooks.
3. Intelligent design
Biomacromolecules are (mostly linear) polymers composed of
a limited repertoire of units (amino acids, nucleotides etc.). For
the purposes of restraint-set deﬁnition, this means that only a
limited set of restraint speciﬁcations are required to cover
most cases. Indeed, after the seminal work of Engh & Huber
(1991, 2001) such speciﬁcations are now available for all
popular reﬁnement and model-building programs, both for
proteins (for bond lengths and angles, although Priestle has
also derived restraints for some torsion angles; Priestle, 2003)
and nucleic acids (Parkinson et al., 1996). For other entities
(‘heterocompounds’) the situation is less favourable, although
restraints for common compounds are often provided with the
programs. In principle, there is an inﬁnite variety of possible
compounds that can be complexed with biomacromolecules
and for every one of these the crystallographer will have to
obtain a sensible set of restraints and a sensible starting model.
The problem is alleviated somewhat through the use of atom-
typing techniques where atoms with similar physical and
chemical properties are treated the same (i.e. they have the
same restraint target values and weights) in all compounds
they occur in. Atom types depend on the chemical element
type, the hybridization state, the charge, the number of
attached H atoms (implicit or explicit) and the chemical
environment. For instance, in many restraint sets for the
programs X-PLOR (Bru ¨nger, 1992) and CNS (Bru ¨nger et al.,
1998), an sp
3-hybridized C atom with two (implicit) H atoms
attached to it is assigned the atom type CH2E, although Engh
& Huber deﬁne two extra types, namely CH2P (in prolines)
and CH2G (in glycines). Many bond-length and bond-angle
restraints have already been deﬁned for such atom types,
which reduces the onus on the crystallographer when creating
restraint sets for new compounds. For instance, the compound
benzene can simply be speciﬁed to consist of six C atoms of
type CR1E that form a six-membered ring. Since this atom
type also occurs in phenylalanine residues, the target values
and weights for the bond lengths and angles will automatically
be the same as those deﬁned by Engh & Huber.
The use of high-quality restraint sets is especially important
for small-molecule ligands since the determination of their
conformation, binding mode and interactions with the
macromolecule is typically the main reason for determining
the crystal structure of the complex in the ﬁrst place. Although
some crystallographers recycle the restraint sets of colleagues,
in general the evolution of such sets does not lead to a high
level of quality. This is one area where ‘intelligent design’ is to
be preferred. The key both to generating and validating
restraint sets (a priori) and to validating the resulting
geometry (a posteriori) is a thorough understanding of the
chemistry of the compound. This enables one to deﬁne the
types of all atoms and to specify all the necessary restraints.
The general rules for specifying stereochemical restraints are
fairly straightforward (Kleywegt et al., 2003; Evans, 2007).
(i) Each pair of bonded atoms yields one bond-length
restraint.
(ii) Two pairs of bonded atoms that have one atom in
common yield one bond-angle restraint.
(iii) A tetrahedral C atom with four different neighbours
(possibly including an implicit H atom) yields one chirality
restraint.
(iv) A (partial) double bond (as in carboxylate groups,
aromatic rings, conjugated systems, peptide bonds etc.) implies
that the atoms involved, as well as all their direct neighbours,
lie in one plane. They thus require planarity restraints and, in
some cases, a speciﬁcation of whether an arrangement is cis or
trans.
(v) A triple bond (or two consecutive double bonds, as in
some aza compounds) requires a linearity restraint.
Particular attention is required when covalent links
between distinct entities are to be deﬁned. This occurs, for
instance, when a suicide inhibitor has reacted with a catalytic
residue, when a post-translational modiﬁcation has occurred
on an amino-acid residue or when a ligand consists of multiple
hetero-entities (such as oligosaccharides). In such cases, bond
lengths, angles and torsion angles need to be deﬁned that
involve atoms from two separate entities (e.g. an amino acid
and a carbohydrate). In addition, a C atom that is achiral in
the isolated compound may become chiral when it is linked to
another entity. A related phenomenon may explain why there
are a few dozen instances of 2-(acetylamino)-2-deoxy- -d-
glucopyranose in the wwPDB (where it is labelled NDG); the
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the exception of the chirality of the C1 atom that links it to an
asparagine residue. It seems likely that some or all of these are
really NAGs that have been reﬁned without a chirality
restraint (or with the wrong target value).
It is important to realise that some restraints are inter-
dependent and others are even redundant (Kleywegt, 2000;
Tronrud, 2004). For instance, if bond angles are restrained by
the corresponding 1–3 distances, the restraints implicitly also
restrain the two 1–2 bond lengths that are involved, and a
similar situation arises when 1–4 distances are used to restrain
torsion angles.
Prior knowledge regarding restraint target values (in
particular, for bond lengths and angles) can be obtained from
different sources, for instance by recycling previously deﬁned
atom types or by looking them up in compilations in papers,
books or websites, or by calculating them from a high-quality
(crystal) structure of the compound of interest. Conforma-
tional torsion angles are not usually restrained and target
values for other restraints (chirality, planarity) tend to follow
immediately from the chemistry of the system (e.g. a torsion-
angle restraint to enforce a trans arrangement around a
double bond implies a restraint target of 180 ).
The proper way to deﬁne restraint sets is to perform a
detailed analysis a ` la Engh & Huber. Besides appropriate
target values, such an analysis also yields reasonable estimates
of the standard deviations of these values. One of the few
examples of such an analysis is the work of Lancaster &
Michel (1997) on the cofactors encountered in the photo-
synthetic reaction centre. For energy-based methods, weights
(or, rather, ‘force constants’) have sometimes been derived
from experimental data (e.g. from infrared spectra). However,
the most common method for deﬁning weights is to simply use
values that are in the same ballpark as those used for proteins.
For bond lengths, the standard deviation is typically set to
0.02 A ˚ (or the corresponding force constant to
1000 kCal mol
 1 A ˚  2); for bond angles a value of 2  is often
used (or a force constant of 500 kCal mol
 1 deg
 2).
4. The twilight zone
Since the construction of high-quality restraint sets is not
trivial, it should come as no surprise that examples of ‘unusual’
ligand stereochemistry abound in the wwPDB (van Aalten et
al., 1996; Kleywegt & Jones, 1998; Kleywegt, 2000; Bostro ¨m,
2001; Nissink et al., 2002; Davis et al., 2003; Kleywegt et al.,
2003; Schu ¨ttelkopf & van Aalten, 2004; Lu ¨tteke & von der
Lieth, 2004). A small number of examples are shown in Fig. 3.
Manual inspection of a large number of such anomalies
suggests that there are a number of different problems that
may occur.
(i) Restraints that should have been applied have been
omitted (or had too low a weight to have had any impact). This
may explain many large distortionsof bond lengths and angles,
as well as unexpected deviations from planarity and incorrect
chirality.
(ii) Restraints that should not have been included have
been applied. This can result in such anomalies as C atoms in
aromatic rings having a tetrahedral arrangement of their
neighbour atoms, of phosphates being trigonal or tetragonal
pyramids etc.
(iii) Restraints have been applied with incorrect target
values. This may, for example, lead to carbon–carbon ‘double’
bonds with lengths of 1.5 A ˚ .
(iv) Finally, there are many errors that cannot easily be
explained in terms of incorrect restraints and that are unlikely
to have been the result of a reﬁnement run. Examples of non-
bonded contacts shorter than 1 A ˚ and of covalent bond
lengths in excess of 5 A ˚ can be found. These are possibly the
result of a posteriori modiﬁcations to the model (either with a
text editor or by dragging atoms around in a modelling
program) which have not subsequently been regularized by a
reﬁnement program.
It is worth noting that errors in ligand stereochemistry occur
in structures in essentially the entire resolution spectrum
(Kleywegt et al., 2003). This merely demonstrates that the
X-ray data alone are insufﬁcient to deﬁne the stereochemistry
of small molecules (although incorrect restraints hardly help
either, of course).
It is important to realise that a restraint set is in essence a
speciﬁcation of the ideal stereochemistry of a compound. In
the best of worlds all the restraints will be satisﬁed, but the old
adage ‘garbage in, garbage out’ applies. If there are incorrect
restraints or restraints with incorrect target values, one should
not be surprised to ﬁnd that the reﬁnement program produces
a chemically implausible model. Similarly, where freedom is
given (i.e. where necessary restraints are omitted or given too
low a weight), liberties will be taken: a reﬁnement program
cannot be more intelligent than its user (yet). Consequently,
the best way to prevent errors in the ﬁrst place is to make sure
that both the restraint set for a compound and its starting
model are of high quality. A useful way to validate a restraint
set is to randomize the coordinates of a ligand and subse-
quently reﬁne it in isolation (i.e. without protein etc. and
without use of the X-ray data). If the resulting geometry is
chemically implausible this means that the restraints are
incomplete, erroneous or conﬂicting.
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Table 1
URLs for some of the resources mentioned in the text.
Resource URL
A La Mode http://ndbserver.rutgers.edu/alamode/
MSDChem http://www.ebi.ac.uk/msd-srv/msdchem/cgi-bin/cgi.pl
HIC-Up http://xray.bmc.uu.se/hicup/
PRODRG http://davapc1.bioch.dundee.ac.uk/programs/prodrg/
prodrg.html
Ligand Depot http://ligand-depot.rutgers.edu/
CSD http://www.ccdc.cam.ac.uk/products/csd/
ICSD http://icsd.ill.fr/dif/icsd/
COD http://www.crystallography.net/
Reciprocal Net http://www.reciprocalnet.org/
NCI Open Database http://cactus.nci.nih.gov/ncidb2/
SWEET http://www.dkfz-heidelberg.de/spec/sweet2/doc/
index.php
RESID http://www.ebi.ac.uk/RESID/5. Tools of the trade
Fortunately, there are a number of resources available to
crystallographers who need plausible starting models and
reasonable restraint sets for small molecules. A few resources
will be discussed here (links are listed in Table 1); several
others can be found in a previous review (Kleywegt et al.,
2003).
Restraint sets can be speciﬁed by anyone with a good
knowledge of chemistry, but the process is tedious, time-
consuming and error-prone (Pa ¨hler & Hendrickson, 1990).
Restraint sets from colleagues should be shunned as a rule,
unless there are strong indications that the colleague is
considerably more skilled, patient and conscientious than
oneself. A collection of validated dictionaries for various
nucleotide units is available from the A La Mode website
(Clowney et al., 1999). Restraint sets for REFMAC
(Murshudov et al., 1997) can be generated from SMILES
strings (Weininger, 1988; Weininger et al., 1989) with AFITT
(Peat et al., 2005) and with CCP4 software (Greaves et al.,
1999; Vagin et al., 2004). These
programs can also be used to draw two-
dimensional diagrams of ligands that
can be converted into structures and
restraint sets.
The MSD database contains a
component called MSDChem that holds
a wealth of information about all
hetero-entities that occur in any
wwPDB entry (Golovin et al., 2004).
Atom types are available for CCP4 and
CNS, the order, length and stereo-
chemistry of bonds is described, both
experimental and ‘ideal’ coordinate sets
are available, REFMAC dictionaries
can be exported etc. The ideal structures
have been generated from SMILES
strings with the program CORINA
(Gasteiger et al., 1990).
HIC-Up (Kleywegt & Jones, 1998) is
a repository of information about
hetero-entities that occur in the
wwPDB. It began in the mid-1990s as a
collection of restraint ﬁles for use with
X-PLOR that had been derived from
coordinate sets taken from wwPDB
entries. Nowadays, restraint sets are
available for X-PLOR/CNS, O and
TNT and most of them have been
derived from the ideal coordinate sets
from MSDChem (as these are often of
higher quality than those taken directly
from the wwPDB entries). In addition
to these coordinate and restraint sets,
HIC-Up also provides a number of links
to external sites for every entry as well
as statistics derived from data stored at
the Electron Density Server (EDS;
Kleywegt et al., 2004); for an example of
the latter, see Table 2. The links from
HIC-Up to EDS enable crystallo-
graphers to assess quickly how the ﬁt of
their ligand to the density compares
with what has been observed in other
structures at similar resolution. They
may also be of use in cases where
interpretation of the density is ambig-
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Figure 3
Examples of errors in heterocompounds encountered in contemporary wwPDB entries. (a)A
sulfate ion as found in a 1.65 A ˚ structure from 1999. One of the O atoms lies in an obviously
impossible location. (b) Geometry of an ‘ideal’ sulfate from MSDChem. (c) Detail of an FAD
molecule found in a 2.3 A ˚ structure from 2005. One of the two phosphates has been subjected to
incorrect restraints (in both copies in the asymmetric unit), forcing it into a tetragonal pyramidal
structure.The otherphosphate has its neighbouring O atoms in the proper tetrahedral arrangement.
(d) A different, but equally wrong, phosphate. This 2.0 A ˚ structural genomics structure from 2002
contains a phosphate forced into a trigonal pyramidal arrangement, with all four P—O bonds
shorter than 1.5 A ˚ (suggesting, incorrectly, that all four are double bonds). In the vicinity of this
phosphate there is a large unoccupied density feature that looks as if it could also accommodate a
phosphate ion (not shown). A nearby residue has density features that show that its peptide bond
needs to be ﬂipped (not shown). These uninterpreted yet obvious density features suggest that the
maps have not been inspected with a great degree of enthusiasm. (e) The N atom in this ligand
(found in a 2.5 A ˚ structure from 2001) appears to have been forced to be planar. In addition, the
bond from the N to the C atom in the other ring is implausibly short (0.8 A ˚ ). (f) The ‘ideal’ structure
of the ligand in (e), taken from MSDChem. The r.m.s. deviation from ideal values of the bond
lengths in the experimental structure is 0.2 A ˚ and the r.m.s. deviation of the angles is 8 .( g)T h i s
poor impersonation of a coenzyme A molecule is found in a 2.25 A ˚ structure from 2003. It contains
non-bonded distances as short as 0.54 A ˚ , bonded distances as long as 6.7 A ˚ and bond angles as small
as 18 .uous. A separate server is available to generate restraint sets
directly from coordinate ﬁles; this can be used for compounds
that are not yet covered by HIC-Up.
PRODRG (van Aalten et al., 1996; Schu ¨ttelkopf & van
Aalten, 2004) is a versatile server for generating coordinates
and restraint sets for a wide variety of reﬁnement, docking,
modelling and molecular-dynamics programs. PRODRG can
handle C, N, O, S, P, Cl, I, Br and Fatoms, which covers a large
fraction of all ligands in the wwPDB as well as most phar-
maceutically relevant compounds. Input to the server can be
provided as a two-dimensional chemical diagram or an ASCII
text drawing. A set of three-dimensional coordinates can also
be supplied but this is actually discouraged.
There are many resources that can be used to obtain a
chemically reasonable starting model of small-molecule
ligands. Experimental coordinates can be extracted from the
wwPDB (with all the associated caveats), either from wwPDB
entries directly or from derived databases such as MSDChem,
HIC-Up and Ligand Depot (Feng et al., 2004). Potentially
more reliable experimental coordinates can be found in
databases that contain small-molecule crystal structures.
Traditionally, chemical databases have not been in the public
domain and this is how two crystallographic databases, the
Cambridge Structural Database (CSD) and the Inorganic
Crystal Structure Database (ICSD), still operate today.
However, in recent years at least two databases have been set
up that make such structures available free of charge: the
Crystallography Open Database (COD) and Reciprocal Net.
Although their coverage is considerably smaller than that of
the CSD, they are a good starting point, in particular for
macromolecular crystallographers without access to the other
databases.
Structures of small molecules can also be calculated without
resorting to crystallographic data. Many packages are avail-
able that calculate structures using ab initio, semi-empirical or
molecular-mechanics methods. A program that is speciﬁcally
tailored to producing restraint sets and that can handle metals
is Hess2FF (Nilsson et al., 2003). There are also many
programs that can convert one-dimensional representations
(such as SMILES strings) or two-dimensional diagrams into a
set of plausible three-dimensional coordinates, including
CORINA, PRODRG and AFITT. CORINA has also been
used in the construction of the NCI Open Database, a freely
accessible database containing three-dimensional coordinates
for more than a quarter of a million compounds. Two useful
specialized resources are RESID (Garavelli, 2004), a database
with (model) structures and information for around 400 types
of modiﬁed and cross-linked amino-acid residues, and SWEET
(Bohne et al., 1999), a server to generate model structures of
simple and complex carbohydrates. A companion resource to
SWEET is PDB-CARE, which is designed to validate carbo-
hydrate structures (Lu ¨tteke & von der Lieth, 2004).
Note added in proof. After this paper had been accepted,
the author found out about two more useful resources,
similar to the NCI Open Database. ChemDB (http://
cdb.ics.uci.edu/CHEM/Web/; Chen et al., 2005) and ZINC
(http://blaster.docking.org/zinc/; Irwin & Shoichet, 2005) both
provide calculated coordinates for more than 4 million
compounds.
The author wishes to acknowledge the many people with
whom he has discussed issues of reﬁnement and validation of
ligand complexes over the past 15 years and on whose
shoulders he was trampling while writing this contribution.
These giants include, among many others, Alwyn Jones
(Uppsala), Eleanor Dodson (York), Phil Evans (Cambridge),
Kim Henrick (Hinxton), Axel Brunger (Stanford), Paul
Adams (Berkeley), Dale Tronrud (Eugene), Alexander
Schu ¨ttelkopf and Daan van Aalten (Dundee), Andy Davis
and Simon Teague (Charnwood), Gert Vriend (Nijmegen) and
Roman Laskowski (Hinxton). The author is a Royal Swedish
Academy of Sciences (KVA) Research Fellow, supported
through a grant from the Knut and Alice Wallenberg Foun-
dation. He is supported by KVA, the Swedish Structural
Biology Network (SBNet), Uppsala University and its
Linnaeus Centre for Bioinformatics.
References
Aalten, D. M. F. van, Bywater, R., Findlay, J. B. C., Hendlich, M.,
Hooft, R. W. W. & Vriend, G. (1996). J. Comput. Aided Mol. Des.
10, 255–262.
Berman, H., Henrick, K. & Nakamura, H. (2003). Nature Struct. Biol.
10, 980.
Bohne, A., Lang, E. & von der Lieth, C. W. (1999). Bioinformatics, 15,
767–768.
Bostro ¨m, J. (2001). J. Comput. Aided Mol. Des. 15, 1137–1152.
research papers
Acta Cryst. (2007). D63, 94–100 Kleywegt   Refinement of ligand complexes 99
Table 2
Example of statistics derived from the Uppsala Electron Density Server
(EDS; Kleywegt et al., 2004) that are available from HIC-Up (Kleywegt &
Jones, 1998).
The table shows real-space R value (RSR) statistics (Jones et al., 1991) for the
heterocompoundNAG(N-acetyl-d-glucosamine).The sample statistics enable
one to assess whether a particular instance of this compound ﬁts well or poorly
at a given resolution in comparison to other structures at similar resolution
(note that lower RSR values indicate a better ﬁt of the model to the density).
On the HIC-Up pages, the PDB codes in the last two columns are in fact links
to the corresponding entries in EDS. This enables one to quickly access
electron-density maps for particularly well or particularly poorly ﬁtting
instances of this compound in any resolution range for which a sufﬁcient
number of instances have been observed. The Z scores indicate how many
sample standard deviations the observed values lie removed from the sample
average [Zi =( R S R i  h RSRi)/ RSR]. In addition to RSR statistics, HIC-Up
also lists EDS-derived statistics pertaining to the real-space correlation
coefﬁcient and isotropic temperature factors.
Resolution
range (A ˚ ) Instances
Average
RSR
St. dev.
RSR
Minimum
(PDB code;
Z score)
Maximum
(PDB code;
Z score)
5.0–3.0 435 0.30 0.13 0.11 (1ism;  1.4) 0.81 (1rer; 3.9)
3.0–2.8 452 0.29 0.12 0.10 (1h15;  1.6) 0.84 (1i1a; 4.5)
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